Publication Name	World Journal of Gastroenterology
Manuscript ID	6908
Country	South Korea

Received	2013-10-29 20:58
Peer-Review Started	2013-11-01 15:24
To Make the First Decision	2013-12-04 09:25
Return for Revision	2013-12-05 18:22
Revised	2014-01-02 11:08
Second Decision	2014-03-13 13:53
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-03-13 16:42
Articles in Press	2014-05-23 11:29
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-06-11 14:11
Publish the Manuscript Online	2014-06-27 10:37

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy
Manuscript Source	Invited Manuscript
All Author List	Jeong Won Jang
Funding Agency and Grant Number
Corresponding Author	Jeong Won Jang, MD, PhD, Associate Professor, Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, #222 Banpo-daero, Seocho-gu, Seoul 137-701, South Korea. garden@catholic.ac.kr
Key Words	Hepatitis B virus; Virus activation; Hepatic morbidity; Hepatocellular carcinoma; Immunosuppression
Core Tip	Hepatitis B virus (HBV) reactivation is a serious hepatic morbidity during anti-cancer therapy. The principal concern relating to reactivation is that a substantial proportion of patients with reactivation suffer from liver dysfunction, which often leads to disruption of planned, potentially life-prolonging treatments, adversely affecting the patients’ final outcome. Given the tumors and underlying cirrhosis, awareness of the management of reactivation is crucial for patients with hepatocellular carcinoma (HCC). This topic provides a summary of the literature and discusses clinical issues of HBV reactivation in HCC patients that are distinct from those in other cancer patients.
Publish Date	2014-06-27 10:37
Citation	Jang JW. Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy. World J Gastroenterol 2014; 20(24): 7675-7685
URL	http://www.wjgnet.com/1007-9327/full/v20/i24/7675.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i24.7675

Full Article (PDF)	WJG-20-7675.pdf
Full Article (Word)	WJG-20-7675.doc
Manuscript File	6908-Review.docx
Answering Reviewers	6908- Answering reviewers.pdf
Copyright License Agreement	6908-Copyright assignment.pdf
Peer-review Report	6908-Peer reviewer(s).pdf
Scientific Editor Work List	6908-Scientific editor work list.doc